157 related articles for article (PubMed ID: 26448177)
1. Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.
Ko YS; Cho SJ; Park J; Kim Y; Choi YJ; Pyo JS; Jang BG; Park JW; Kim WH; Lee BL
Br J Cancer; 2015 Oct; 113(8):1186-96. PubMed ID: 26448177
[TBL] [Abstract][Full Text] [Related]
2. FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
Park J; Choi Y; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Park JW; Lee BL
Cancer Res Treat; 2018 Jan; 50(1):239-254. PubMed ID: 28343375
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.
Kim SY; Ko YS; Park J; Choi Y; Park JW; Kim Y; Pyo JS; Yoo YB; Lee JS; Lee BL
Cancer Res Treat; 2016 Jan; 48(1):345-54. PubMed ID: 25761483
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells.
Choi Y; Park J; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Lee BL
Biochem Biophys Res Commun; 2017 Nov; 493(3):1349-1355. PubMed ID: 28970066
[TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.
Guan SS; Wu CT; Chiu CY; Luo TY; Wu JY; Liao TZ; Liu SH
J Transl Med; 2018 Jun; 16(1):168. PubMed ID: 29921305
[TBL] [Abstract][Full Text] [Related]
6. Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
Du F; Feng W; Chen S; Wu S; Cao T; Yuan T; Tian D; Nie Y; Wu K; Fan D; Xia L
Cancer Lett; 2019 Jun; 452():103-118. PubMed ID: 30922917
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization.
Xie C; Guo Y; Lou S
Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487
[TBL] [Abstract][Full Text] [Related]
8. CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2.
Qi M; Jiao M; Li X; Hu J; Wang L; Zou Y; Zhao M; Zhang R; Liu H; Mi J; Zhang L; Liu L; Gong Y; Han B
Oncogene; 2018 Feb; 37(8):1075-1085. PubMed ID: 29106389
[TBL] [Abstract][Full Text] [Related]
9. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
[TBL] [Abstract][Full Text] [Related]
10. HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.
Choi Y; Ko YS; Park J; Choi Y; Kim Y; Pyo JS; Jang BG; Hwang DH; Kim WH; Lee BL
World J Gastroenterol; 2016 Nov; 22(41):9141-9153. PubMed ID: 27895401
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
12. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG
Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125
[TBL] [Abstract][Full Text] [Related]
13. Stanniocalcin‑1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl‑2.
Wang Y; Qi Z; Zhou M; Yang W; Hu R; Li G; Ma X; Zhang Z
Oncol Rep; 2019 Mar; 41(3):1998-2008. PubMed ID: 30747219
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer.
Shan T; Fan J; Zhao Q; Deng K; Xia J
Mol Med Rep; 2017 Oct; 16(4):3761-3768. PubMed ID: 28731138
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
Fan C; Liu S; Zhao Y; Han Y; Yang L; Tao G; Li Q; Zhang L
Biomed Pharmacother; 2013 Jul; 67(6):521-6. PubMed ID: 23721824
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-92a promotes proliferation and invasiveness of gastric cancer cell by targeting FOXO1 gene.
Yu J; Ni Q; Zhang S; Hua R; Tao R; Tang C; Feng S
Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):95-100. PubMed ID: 32359391
[TBL] [Abstract][Full Text] [Related]
17. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.
Zuo QF; Cao LY; Yu T; Gong L; Wang LN; Zhao YL; Xiao B; Zou QM
Cell Death Dis; 2015 Nov; 6(11):e2000. PubMed ID: 26610210
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric cancer growth and metastasis by regulating multiple matrix metallopeptidase expression.
Shan ZG; Sun ZW; Zhao LQ; Gou Q; Chen ZF; Zhang JY; Chen W; Su CY; You N; Zhuang Y; Zhao YL
J Gastroenterol Hepatol; 2021 Jan; 36(1):196-203. PubMed ID: 32537806
[TBL] [Abstract][Full Text] [Related]
20. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.
Park J; Ko YS; Yoon J; Kim MA; Park JW; Kim WH; Choi Y; Kim JH; Cheon Y; Lee BL
Gastric Cancer; 2014; 17(3):423-30. PubMed ID: 24202965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
